Nuveen Asset Management, LLC Intra Cellular Therapies, Inc. Put Options Transaction History
Nuveen Asset Management, LLC
- $340 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ITCI
# of Institutions
71Shares Held
14.6MCall Options Held
38KPut Options Held
3.6K-
Black Rock Inc. New York, NY6.32MShares$834 Million0.01% of portfolio
-
Pictet Asset Management Sa Geneva 73, V81.67MShares$220 Million0.13% of portfolio
-
Jpmorgan Chase & CO New York, NY760KShares$100 Million0.01% of portfolio
-
Eagle Asset Management Inc St Petersburg, FL625KShares$82.4 Million0.27% of portfolio
-
Magnetar Financial LLC Evanston, IL436KShares$57.5 Million2.12% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $12.4B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...